US 11001631
Clec9A binding agents
granted A61KA61K2039/505A61K2039/57
Quick answer
US patent 11001631 (Clec9A binding agents) held by Orionis Biosciences, Inc expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K2039/57, A61K38/00, A61K39/395